My place, your place, or a safer place - The intention among Montreal injecting drug users to use supervised injecting facilities

被引:29
作者
Green, TC
Hankins, CA
Palmer, D
Boivin, JF
Platt, R
机构
[1] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[2] Montreal Reg Publ Hlth Dept, Montreal, PQ, Canada
[3] Inst Natl Sante Publ Quebec, Montreal, PQ, Canada
来源
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE | 2004年 / 95卷 / 02期
关键词
D O I
10.1007/BF03405777
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Supervised injection facilities (SIF), a harm reduction intervention, may reduce several risks of public injection drug use. The prospect of conducting a scientific, multi-site pilot project of these facilities is being explored at federal and local levels in Canada. Experiences with SIF in Europe and Australia indicate that successful outcomes for the community ultimately hinge upon the responsiveness and relevance of the facilities to the needs of their primary target group: people who inject drugs in public places. Consideration of the factors and conditions found to influence a potential user's uptake of SIF, therefore, is imperative. This study sought to assess the acceptability of SIF and to determine factors associated with willingness of injecting drug users (IDU) to use SIF in a city considering their establishment. Methods: From April 2001 to February 2002, following key informant interviews, a cross-sectional study was conducted among publicly injecting IDU participating in an ongoing HIV surveillance study in Montreal. Univariate and bivariate analyses preceded logistic regression. Results: Participants were 11 key informants and 251 publicly injecting IDU. Key informants generated the Montreal-specific SIF model subsequently presented to IDU. 76% of IDU were willing to use at least one of three proposed SIF sites. Exploratory multivariable models indicated drug-use characteristics and SIF attributes as determinants of outcome: predominant cocaine injection, history of overdose, knowing about SIF, relieving and empowering feelings toward using SIF, and comfort with disclosure of one's injecting drug use.
引用
收藏
页码:110 / 114
页数:5
相关论文
共 28 条
[1]  
de Jong W, 1999, INT J DRUG POLICY, V10, DOI [DOI 10.1016/S0955-3959(98)00072-73, 10.1016/S0955-3959(98)00072-3, DOI 10.1016/S0955-3959(98)00072-3]
[2]   Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia [J].
Dolan, K ;
Kimber, J ;
Fry, C ;
Fitzgerald, J ;
McDonald, D ;
Trautmann, F .
DRUG AND ALCOHOL REVIEW, 2000, 19 (03) :337-346
[3]  
ELLIOTT R, 2002, ESTABLISHING SAFE IN
[4]  
*FED PROV TERR ADV, 2001, F P T COMM ALC OTH D
[5]  
FISCHER B, 2001, JOURN SCI LIEUX INJ
[6]   Establishing safe injecting rooms in Australia: attitudes of injecting drug users [J].
Fry, C ;
Fox, S ;
Rumbold, G .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 1999, 23 (05) :501-504
[7]  
FRY C, 2000, NOT JUST FOR US SAFE
[8]  
GREEN TC, 2002, THESIS MCGILL U
[9]   Continuing HIV transmission among injection drug users in Eastern Central Canada: The SurvUDI study, 1995 to 2000 [J].
Hankins, C ;
Alary, M ;
Parent, R ;
Blanchette, C ;
Claessens, C .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 30 (05) :514-521
[10]  
HANKINS C, 2000, P 13 INT AIDS C DURB